It is a business services public limited company based in Delhi, Delhi, India, established in 2018.
2018 | Delhi, Delhi, India | ActiveRadicon Pharmaceuticals Limited, a active public limited company, was established on 07 June 2018 in Delhi, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999DL2018PLC334969. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Tanishq (Director), Rakesh Bhutani (Director), Kunal Arora (Director). Past directors included Rakesh Bhutani, Jitender Ahuja, Kunal Arora. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7/26 B, Jwala Nagar, Shahdara Near Ahuja Tent House, Delhi, Delhi, 110032.
U74999DL2018PLC334969
334969
07 June 2018
₹1.00 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Radicon Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tanishq | Director | 07 Jun 2018 | Current |
| Rakesh Bhutani | Director | 02 Jun 2020 | Current |
| Kunal Arora | Director | 01 Apr 2019 | Current |
| Sumitra | Director | 07 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2019 | Past |
| Pramod Abcsdd | Additional Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Director | 24 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Radicon Pharmaceuticals Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 306.43% decrease in profit. The company's net worth dipped by a decrease of 2.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Radicon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Radicon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Radicon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Radicon Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Radicon Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Rakesh Bhutani was appointed as a Director was appointed as a Director on 02 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
Progress on Kunal Arora was appointed as a Director was appointed as a Director on 01 Apr 2019 & has been associated with this company since 6 years 8 months . was documented.
The activity Tanishq was appointed as a Director was appointed as a Director on 07 Jun 2018 & has been associated with this company since 7 years 5 months . was completed.
The activity Sumitra was appointed as a Director was appointed as a Director on 07 Jun 2018 & has been associated with this company since 7 years 5 months . was completed.
The CIN of Radicon Pharmaceuticals Limited is U74999DL2018PLC334969.
Radicon Pharmaceuticals Limited is headquartered at 7/26 B, Jwala Nagar, Shahdara Near Ahuja Tent House, Delhi, Delhi, 110032.
Radicon Pharmaceuticals Limited was incorporated on 07 June 2018.
The current directors of Radicon Pharmaceuticals Limited are
The primary industry of Radicon Pharmaceuticals Limited is Business Services.
Radicon Pharmaceuticals Limited is unlisted.
The authorized capital of Radicon Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX